Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Hypogammaglobulinemia (HGG) is a frequent finding in patients with hematological malignancies, and is commonly described in chronic lymphocytic leukemia (CLL) before or after treatment. We reviewed published literature available online in the last thirty years through Medline search of indexed artic...
Main Authors: | Alessandro Noto, Ramona Cassin, Veronica Mattiello, Marta Bortolotti, Gianluigi Reda, Wilma Barcellini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1062376/full |
Similar Items
-
Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored
by: Qinggang Zhang, et al.
Published: (2024-03-01) -
Fresh-frozen plasma as a low-cost replacement of intravenous immunoglobulin for the treatment of symptomatic hypogammaglobulinemia
by: Pankaj Kumar, et al.
Published: (2023-01-01) -
Low immunoglobulin levels affect the course of COPD in hospitalized patients
by: Nami Shrestha Palikhe, et al.
Published: (2023-01-01) -
Hypogammaglobulinemia Prevelance in Children with Atopic Dermatitis and the Relationship Between Immunoglobulin Levels and Eczema Severity
by: Burçin BEKEN, et al.
Published: (2021-12-01) -
An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies
by: Sujoy Khan, et al.
Published: (2023-04-01)